| Literature DB >> 35164874 |
Boubacar Efared1,2, Aïchatou Balaraba Abani Bako3,4, Boubacar Idrissa5, Daouda Alhousseini3,6, Habiba Salifou Boureima4, Haboubacar Chaibou Sodé7, Hassan Nouhou3.
Abstract
BACKGROUND: Schistosomiasis is still a public health issue in certain areas of developing countries (especially in sub-saharan Africa). Schistosoma haematobium is a proven carcinogenic agent that causes mainly bladder squamous cell carcinoma. This type of cancer has characteristic epidemiological, clinical and histopathological features with poor prognosis as compared to other urinary bladder cancers not associated with this parasite. CASESEntities:
Keywords: Bladder cancer; Schistosomiasis; Squamous cell carcinoma
Year: 2022 PMID: 35164874 PMCID: PMC8845255 DOI: 10.1186/s40794-022-00161-x
Source DB: PubMed Journal: Trop Dis Travel Med Vaccines ISSN: 2055-0936
Fig. 1Case 1: Histological image showing a well differentiated and keratinized squamous cell carcinoma associated with Schistosoma haematobium calcified eggs (arrows) (hematoxylin and eosin stain × 200)
Fig. 2Case 2: Macroscopic resected specimens (after formalin fixation and inking) showing the partial cystectomy largely occupied by an ill-defined infiltrative whitish tumor, with 2 epiploic fragments invaded by tumoral nodules (arrows)
Fig. 3Case 2: Histological image showing a well differentiated and keratinized squamous cell carcinoma associated A, with Schistosoma haematobium calcified eggs with their characteristic terminal spine B (hematoxylin and eosin stain × 100)
urinary bladder main carcinomas and their differential characteristics
| Characteristics | Urothelial carcinoma | Non-Schistosoma-related Squamous cell carcinoma | Schistosoma-related squamous cell carcinoma |
|---|---|---|---|
| Geographic distribution: | |||
| - Industrialised countries | - Frequent | - Rare | - Rare |
| - Areas with endemic schistosomiasis | - Rare | - Rare | - Frequent |
| Main risk factors | Tobacco, toxic industrial chemicals | Tobacco, chronic bladder irritation (indwelling catheter, calculi) | Chronic |
| Age (years) | Sixth-seventh decade | Sixth-seventh decade | Third-forth decade |
| Clinical stage at presentation | Usually limited | Usually advanced | Usually advanced |
| Macroscopic aspect | Polypoïd, fungating appearance | Nodular, bulky aspect | Nodular, bulky aspect |
| Histological differenciation | Urothelial cell phenotype with or without squamous cell differenciation | Pure squamous cell phenotype | Pure squamous cell phenotype |
| Histological precursors | Urothelial hyperplasia/urothelial carcinoma in situ | Squamous metaplasia | Squamous metaplasia |
| Radio-Chemotherapy response | Better | Poorer | Poorer |
| Prognosis | Better | Poorer | Poorer |